PORTLAND, Maine (NEWS CENTER) -- Promising new clinical trial for people with metastatic breast cancer. That is one that starts in the breast and moves through the lymph nodes and into other parts of the body. There is no telling where the cancer will show up next.
The goal in treating these patients shifts to slowing the progression of the cancer. Thereby prolonging their life.
On tonight's Buddy to Buddy report, we look at a promising new drug trial going on here in Maine, that is offering hope.
Dr. Chiara Battelli is an Oncologist at Maine Medical Center, who regularly considers clinical trials as avenues of treatment for her patients. She is excited about this trial in particular because this new drug Palbociclib has dramatically slowed the progression of cancer in patients involved in the two previous phases.
Metastatic cancer patients will take a drug that stops or slows the growth of their disease until that drug stops working...which they all do at some point and then move on to the next drug.
In previous trials this drug stopped the progression of cancers for an average of 20 months and in this field, that's a long time. It's in a pill form so there are no IV's involved.
But perhaps the best thing about this type of drug is the side effects aren't nearly as harsh as chemotherapy.
FMI: Clinical Trials